Previous work from our lab demonstrated that WFA treatment results in a reduction in activation/nuclear translocation of the canonical NF-κB signaling pathway component p65 within the xenografted tumor (Straughn and Kakar, 2019). Here, NFKB1 is linked to neoplasm.